Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1

Thomas Thum, Sarah Hoeber, Sabrina Froese, Ivonne Klink, Dirk O. Stichtenoth, Paolo Galuppo, Marten Jakob, Dimitrios Tsikas, Stefan D. Anker, Philip A. Poole-Wilson, Jürgen Borlak, Georg Ertl, Johann Bauersachs

Research output: Contribution to journalArticlepeer-review

Abstract

Aging is associated with an increased risk for atherosclerosis. A possible cause is low numbers and dysfunction of endothelial progenitor cells (EPC) which insufficiently repair damaged vascular walls. We hypothesized that decreased levels of insulin-like growth factor-1 (IGF-1) during age contribute to dysfunctional EPC. We measured the effect of growth hormone (GH), which increases endogenous IGF-1 levels, on EPC in mice and human subjects. We compared EPC number and function in healthy middle-aged male volunteers (57.4±1.4 years) before and after a 10 day treatment with recombinant GH (0.4 mg/d) with that of younger and elderly male subjects (27.5±0.9 and 74.1±0.9 years). Middle-aged and elderly subjects had lower circulating CD133/VEGFR-2 EPC with impaired function and increased senescence. GH treatment in middle-aged subjects elevated IGF-1 levels (126.0±7.2 ng/mL versus 241.1±13.8 ng/mL; P

Original languageEnglish
Pages (from-to)434-443
Number of pages10
JournalCirculation Research
Volume100
Issue number3
DOIs
Publication statusPublished - Feb 2007

Keywords

  • Aging
  • Endothelial progenitor cells
  • Growth hormone
  • Insulin-like-growth-factor-1

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1'. Together they form a unique fingerprint.

Cite this